Business · 09/01/2012Updated: 10/17/2026 · 1 min read
FDA Announces Alteration to Bioresearch Monitoring Information System
Summary
The Food and Drug Administration (FDA) is updating its Bioresearch Monitoring Information System, adding new routine uses for disclosures of certain information to agencies, authorities, and organizations involved in clinical investigations and research, as well as individuals who require access to records for FDA services.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →